Intermittently Delivered IV Medication and pH: Reevaluating the Evidence

Journal of Infusion Nursing

Volumn 38, Issue 1, 2015, Pages 27-46

  Gorski, Lisa A ^a   Hagle, Mary E ^b,c   Bierman, Steve ^d  

^a Wheaton Franciscan Home Health and Hospice   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d Access Scientific Inc   (United States)

Author keywords

chemical phlebitis; infusion thrombophlebitis; peripheral catheterization; pH; thrombophlebitis

Indexed keywords

AMIODARONE; AMPICILLIN; ANTIBIOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CEFAMANDOLE; CIMETIDINE; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; METHOHEXITAL; POTASSIUM CHLORIDE; TEICOPLANIN; VANCOMYCIN;

ARTICLE; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CONTINUOUS INFUSION; DRUG INTERMITTENT THERAPY; EVIDENCE BASED PRACTICE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PH; PHLEBITIS; PRIORITY JOURNAL; THROMBOPHLEBITIS; VASCULAR ACCESS; DECISION MAKING; EVIDENCE BASED NURSING; NURSING;

CATHETERIZATION, CENTRAL VENOUS; DECISION MAKING; EVIDENCE-BASED NURSING; HUMANS; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; THROMBOPHLEBITIS;

EID: 84920747100     PISSN: 15331458     EISSN: 15390667     Source Type: Journal    
DOI: 10.1097/NAN.0000000000000081     Document Type: Article

References (42)

1. Infusion Nurses Society. Infusion nursing standards of practice. J Intraven Nurs. 1998 ; 21 (suppl 6): S49.
2. Infusion Nurses Society. Infusion nursing standards of practice. J Intraven Nurs. 2000 ; 23 (suppl 6): S37-S38.
3. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2006 ; 29 (suppl 1): S37-S38.
4. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2011 ; 34 (suppl 1): S37-S38.
5. Chopra V, O'Horo JC, Rogers MAM, Maki DG, Safdar N. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2013 ; 34 (9): 908-918.
6. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006 ; 81 (9): 1159-1171.
7. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005 ; 128 : 489-495.
8. Fakih MG, Jones K, Rey JE, et al. Sustained improvements in peripheral catheter care in non-intensive care units: a quasiexperimental controlled study of education and feedback. Infect Control Hosp Epidemiol. 2012 ; 33 (5): 449-455.
9. Mestre G, Berbel C, Tortajada P, et al. Successful multifaceted intervention aimed to reduce short peripheral venous catheterrelated events: a quasi-experimental cohort study. Am J Infect Control. 2013 ; 41 (6): 520-526.
10. Trinh TT, Chan PA, Edwards O, et al. Peripheral venous catheterrelated Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2011 ; 32 (6): 579-583.
11. Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013 ; 382 (9889): 311-325.
12. Itkin M, Mondshein JI, Stravropoulos WS, Shlansky-Goldberg RD, Soulen MC, Trerotola SO. Peripherally inserted central catheter thrombosis-reverse tapered versus nontapered catheters: a randomized controlled study. J Vasc Intervent Radiol. 2014 ; 25 (1): 85-91.
13. Chopra V, Flanders SA, Saint S. The problem with peripherally inserted catheters. JAMA. 2012 ; 308 (15): 1527-1528.
14. Caparas JV, Hu JP. Safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial. J Vasc Access. 2014 ; 15 (4): 251-256.
15. Lewis GBH, Hecker JF. Infusion thrombophlebitis. Br J Anaesth. 1985 ; 57 (2): 220-233.
16. Perucca R. Peripheral vascular access devices. In: Alexander M, Corrigan A, Gorski L, Hankins J, Perucca R, eds. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St Louis, MO : Saunders/Elsevier ; 2010 : 571-582.
17. Jones ER. Relationship between pH of intravenous medications and phlebitis: an experimental study. NITA. 1982 ; 5 (4): 273-276.
18. Bartz C. Phlebitis with intravenous infusion: influence of pH, duration of infusion, and rate of flow. Milit Med. 1982 ; 147 : 109-114.
19. Eremin O, Marshall V. Complications of intravenous therapy: reduction by buffering of intravenous fluid preparation. Med J Aust. 1977 ; 2 (16): 528-531.
20. Harrigan CA. A cost-effective guide for the prevention of chemical phlebitis caused by the pH of the pharmaceutical agent. NITA. 1984 ; 7 (6): 478-482.
21. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Ann Intern Med. 1991 ; 114 (10): 845-854.
22. Ryder MA. Peripheral access options. Surg Oncol Clin North Am. 1995 ; 4 (3): 395-427.
23. Ryder MA. Device selection: a critical strategy in the reduction of catheter-related complications. Nutrition. 1996 ; 12 (2): 143-145.
24. Campbell L. IV-related phlebitis, complications and length of hospital stay: 1. Br J Nurs. 1998a ; 7 (21): 1304-1306, 1308-1312.
25. Hecker JF. Improved technique in IV therapy. Nurs Times. 1988 ; 84 (34): 28-33.
26. Campbell L. IV-related phlebitis, complications and length of hospital stay: 2. Br J Nurs. 1998b ; 7 (22): 1364-1366, 1368-1370, 1372-1373.
27. Robibaro B, Vorbach H, Weigel G, et al. Endothelial cell compatibility of glycopeptide antibiotics for intravenous use. J Antimicrob Chemother. 1998 ; 41 : 297-300.
28. Simamora P, Pinsuwan S, Alvarez JM, Myrdal PB, Yalkowsky SH. Effect of pH on injection phlebitis. J Pharm Sci. 1995 ; 84 (4): 520-522.
29. Kuwahara T, Asanami S, Kawauchi Y, Kubo S. Experimental infusion phlebitis: tolerance pH of peripheral vein. J Toxicol Sci. 1999 ; 24 (2): 113-121.
30. Monreal M, Quilez F, Rey-Joly C, et al. Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest. 1999 ; 115 (6): 1576-1580.
31. Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med. 2002 ; 113 (2): 146-151.
32. Stratton CW. Infection related to intravenous infusions. Heart Lung. 1982 ; 11 (2): 123-133.
33. Lanbeck P, Odenholt I, Paulsen O. Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis. 2002 ; 34 (7): 512-519.
34. Stranz M, Kastango ES. A review of pH and osmolarity. Int J Pharm Compd. 2002 ; 6 (3): 216-220.
35. Vesely TM, Stranz M, Masoorli S, Hadaway LC. The diverse and conflicting standards and practices in infusion therapy. J Vasc Access Devices. 2002 ; 7 (3): 9-25.
36. Hawes ML. A proactive approach to combating venous depletion in the hospital setting. J Infus Nurs. 2007 ; 30 (1): 33-44.
37. Tripathi S, Kaushik V, Singh V. Peripheral IVs: factors affecting complications and patency-a randomized controlled trial. J Infus Nurs. 2008 ; 31 (3): 182-188.
38. Cicolini G, Bonghi AP, Labio LD, et al. Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observational study. J Adv Nurs. 2009 ; 65 (6): 1268-1273.
39. Roszell S, Jones C. Intravenous administration issues: a comparison of intravenous insertions and complications in vancomycin versus other antibiotics. J Infus Nurs. 2010 ; 33 (2): 112-118.
40. Mowry JL, Hartman LS. Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin. West J Nurs Res. 2011 ; 33 (3): 457-471.
41. Dychter SS, Gold DA, Carson D, Haller M. Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infus Nurs. 2012 ; 35 (2): 84-91.
42. Hadaway L, Chamallas SN. Vancomycin: new perspectives on an old drug. J Infus Nurs. 2003 ; 26 (5): 278-284.